Lorcaserin Hydrochloride cas 846589-98-8 for Treatment Of Obesity   (jerryzhang001@chembj.com) - Nanjing Bangnuo Biotechnology Co., Ltd.

Lorcaserin Hydrochloride cas 846589-98-8 for Treatment Of Obesity   (jerryzhang001@chembj.com)

PRICE: 5 USD
Company:
Nanjing Bangnuo Biotechnology Co., Ltd.
Contact Person:
Jerry Zhang
Phone:
86-25-52198306


Product Description

Lorcaserin Hydrochloride CAS 846589-98-8 for treatment of obesity

 

  1. Description

Lorcaserin, currently marketed under the trade name Belviq and previously Lorqess during development, is a weight-loss drugdeveloped by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic.

Lorcaserin is a new drug for the treatment of obesity , belonging to oral potent selective serotonin 2C receptor agonists, lorcaserin hydrochloride is successfully developed by the US company Arena, on June 27, 2012 by the US FDA it is approved for marketing, as adjuvant therapy for obesity or merge with at least one weight-related complications in overweight adults in low-calorie diet and exercise basis .


Other products

Join Free